Article by Ozawa and Tsuzuki Published in Yodosha's Jikken Igaku Supplement 'Multi-omics: Disease Research in the Data-Driven Era'
An article by our team members Ozawa and Tsuzuki titled “Integration of Public Omics Data and Hypothesis Generation Based on OSINT” will be published in Yodosha’s Jikken Igaku (Experimental Medicine) Supplement “Multi-omics: Disease Research in the Data-Driven Era.”
The article proposes a methodology for data integration and hypothesis generation based on the concept of “Open Source Intelligence (OSINT),” addressing the challenge of research interest and resources being concentrated on specific molecules.
Publication Details
- Book: Jikken Igaku Supplement: Multi-omics — Disease Research in the Data-Driven Era
- Article title: Integration of Public Omics Data and Hypothesis Generation Based on OSINT
- Authors: Taku Tsuzuki, Risa Okamoto, Junichi Maruyama, Yosuke Ozawa, Katsuyuki Kakinoki
https://www.yodosha.co.jp/jikkenigaku/book/9784758104135/index.html
Related Articles
Won Grand Prix in the 7th IP BASE AWARD Startup Category Hosted by the Japan Patent Office
On March 3, 2026, Epistra Inc. won the Grand Prix in the startup category at the '7th IP BASE AWARD' ceremony hosted by the Japan Patent Office.
Jikkenigaku Special Issue 'AI and Data-Driven Drug Discovery Research' Published — CTO Tsuzuki Authors Chapter on AI-Driven Drug Target Discovery
In 'Jikkenigaku Special Issue: AI and Data-Driven Drug Discovery Research' published by Yodosha, our CTO Taku Tsuzuki authored a chapter on AI-driven knowledge mining for drug target discovery.
Speaking Engagement: Delivered Keynote at the 10th Cell Manufacturing Kotozukuri Symposium
On March 4, 2026, CEO Yosuke Ozawa delivered a keynote speech on optimizing cell manufacturing processes using AI and robotics at the '10th Cell Manufacturing Kotozukuri Symposium' hosted by Osaka University.